Arquivamento definitivo - Art. 33 da LPI
#11.1.1
12/11/2007
RPI 1927
Application data
Number
PI0317413Type
Filing
Publication
PCT
US2003040078 The application was abandoned: examination was not requested within the 36 months following the 12/16/2003 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 12/11/2007. We update with every new RPI gazette, published weekly.
Applicants
Aventis Pharmaceuticals INC.
US
Inventors
B. Z. (pessoa física)
US
J. W. (pessoa física)
US
M. P. (pessoa física)
US
IPC Classification
Priority claims
US
60/434,003 · 12/17/2002
Abstract
"USO DE TIAZOLOBENZOHETEROCICLOS PARA O TRATAMENTO DE ESCLEROSE MÚLTIPLA". A presente invenção refere-se ao uso de um composto de Fórmula I para fabricar um medicamento para o tratamento de pacientes para dor inflamatória ou neuropática assim como de vários sintomas de esclerose múltipla.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
12/11/2007
RPI 1927
#11.1
09/04/2007
RPI 1913
#1.3
11/08/2005
RPI 1818
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.